Comprehensive Atopic Dermatitis Care: Enhancing Patient Care through Collaborative Management 9.21.21
Led by a nationally renowned faculty team of dermatology experts, this curriculum will spotlight various aspects of a multidimensional, holistic treatment approach for pediatric patients with atopic dermatitis (AD). The presentation will provide discussion around the recent advances in the AD treatment landscape, evidence-based recommendations for care, including therapeutic patient education (TPE) regarding behavioral modifications or habit reversal techniques for itch, strategies for care coordination and appropriate referrals among dermatology specialists to better support a connected, co-management approach, and through the use of patient storytelling, acknowledging the quality of life burden of patients with AD with tools to better understand how to manage quality of life aspects within the context of symptom control and overall disease management. The program will conclude with key teaching points and an opportunity for Q&A.
This activity has been designed to meet the educational needs of pediatricians who are involved in the care and treatment of patients with atopic dermatitis.
At the conclusion of this activity, participants will be able to:
- Review strategies to overcome gaps in AD care, including identification, prevention, guideline adherence, and reducing disease burden.
- Assess current pharmacologic and non-pharmacologic options for treatment of AD in the pediatric population.
- Discuss best practice strategies for the care coordination of atopic dermatitis (AD) with specialists based on evidence-based standards and holistic treatment approach practices.
- Utilizing video vignettes of actual patients, recognize the quality of life burdens with AD including factors such as emotional and psychosocial effects, sleep disturbances, and decreased attention span and productivity.
Eu sem integer vitae justo eget magna fermentum.
Peter A Lio, MD
Assistant Professor of Clinical Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Director, Chicago Integrative Eczema Center
Founding Partner, Medical Dermatology Associates of Chicago
Dr. Peter Lio is on the advisory board for Arbonne, Johnson and Johnson, Derm Tap, Inc., Intraderm Pharmaceuticals, Regeneron, Sanofi US Services, Realm Therapeutics, Menlo Therapeutics, Modernizing Medicine, Syncere Skin Systems, DermVeda, gpower inc., UCB, Altus Labs, Dermavant Sciences, Micreos Human Health B.V., and Verrica Pharmaceuticals Inc.; is a speaker for Regeneron and La Roche-Posay Laboratorie Pharmaceutique.; is a consultant for Exeltis, Theraplex, Odeza LLC, L'Oreal USA Inc., Franklin BioScience, AbbVie, Kiniksa Pharmaceuticals, Ltd, Eli Lilly and Company, Unilever, Dermira TopMD, Amyris, Inc., and LEO Laboratories Ltd . Dr. Lio is also a stockholder for Derm Tap, Inc., LearnHealth/LearnSkin, Modernizing Medicine, Pfizer Inc. and Pierre Fabre Dermatologie and also receives patent royalties from Theraplex.
CME Project Manager: Michael Burk
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
- 1.00 AAPThis continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation
Feugiat pretium nibh ipsum consequat nisl vel pretium lectus. Vehicula ipsum a arcu cursus vitae congue mauris rhoncus. Morbi leo urna molestie at elementum. Eget duis at tellus at. Molestie at elementum eu facilisis sed odio morbi quis. Egestas congue quisque egestas diam in arcu cursus euismod. Nunc scelerisque viverra mauris in aliquam sem fringilla ut. Sagittis nisl rhoncus mattis rhoncus urna neque. Viverra maecenas accumsan lacus vel. Purus in massa tempor nec feugiat nisl pretium fusce. Facilisi morbi tempus iaculis urna id. In vitae turpis massa sed elementum. Non tellus orci ac auctor augue mauris augue neque gravida. Diam sit amet nisl suscipit adipiscing bibendum est. Enim sit amet venenatis urna cursus. Velit ut tortor pretium viverra suspendisse potenti. Aliquam ultrices sagittis orci a scelerisque purus semper eget. Nisl purus in mollis nunc sed id. Turpis nunc eget lorem dolor sed viverra ipsum nunc.
Lobortis feugiat vivamus at augue. Id velit ut tortor pretium viverra suspendisse potenti nullam ac. Netus et malesuada fames ac turpis egestas integer eget. Augue ut lectus arcu bibendum at varius vel. Mattis molestie a iaculis at erat pellentesque adipiscing. Vitae semper quis lectus nulla at volutpat diam. Et malesuada fames ac turpis. Eu non diam phasellus vestibulum. Pellentesque elit ullamcorper dignissim cras tincidunt lobortis feugiat. Ligula ullamcorper malesuada proin libero nunc consequat interdum varius. Congue mauris rhoncus aenean vel. Imperdiet dui accumsan sit amet nulla facilisi morbi tempus iaculis. Ultrices vitae auctor eu augue. Egestas maecenas pharetra convallis posuere morbi leo. Faucibus et molestie ac feugiat sed lectus vestibulum. Viverra nam libero justo laoreet sit amet cursus sit. Justo donec enim diam vulputate ut pharetra sit amet.